Congenital syphilis case investigation and report panel [CDC.CS] 75199-0
LOINC Code
LOINC code | 75199-0 | ||||
---|---|---|---|---|---|
name | Congenital syphilis case investigation and report panel [CDC.CS] | ||||
description | This panel represents CDC's Congenital Syphilis Case Investigation and Report form (CDC 73.126 REV. 02-2013) used by health officials who identify infants or children of recently pregnant women who may be infected with Treponema pallidum. The information is used to determine whether an infant or child meet the criteria for CDC/Council for State and Territorial Epidemiology (CSTE) surveillance case definition of congenital syphilis (CS). | ||||
status | ACTIVE | ||||
Fully-Specified Name | |||||
component | Congenital syphilis case investigation and report panel | ||||
property | - | ||||
time | Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements. | ||||
system | ^Patient | ||||
scale | - | ||||
method | CDC.CS | ||||
Additional Names | |||||
short name | |||||
Basic Attributes | |||||
class | PANEL.SURVEY.CDC | ||||
type | 4 Surveys | ||||
order vs. observation | Order | ||||
Panel Components | |||||
| |||||
Associated Observations | |||||
LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations. | |||||
History/Usage | |||||
first released | |||||
last updated | 2.48 | ||||
last change type | MIN - change to field other than name | ||||
Related Names | |||||
|
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.